These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 20710066
1. Synthesis and biological evaluation of heat-shock protein 90 inhibitors: geldanamycin derivatives with broad antiviral activities. Li YP, Shan GZ, Peng ZG, Zhu JH, Meng S, Zhang T, Gao LY, Tao PZ, Gao RM, Li YH, Jiang JD, Li ZR. Antivir Chem Chemother; 2010 Aug 11; 20(6):259-68. PubMed ID: 20710066 [Abstract] [Full Text] [Related]
2. [Synthesis and antiviral activities of geldanamycin analog TC-GM in vitro]. Li CX, Shan GZ, Fan B, Tao PZ, Zhao LX, Jiang JD, Li YH, Li ZR. Yao Xue Xue Bao; 2011 Jun 11; 46(6):683-7. PubMed ID: 21882529 [Abstract] [Full Text] [Related]
3. A novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90: synthesis, structure-activity relationships and anti-HCV activity in GS4.3 replicon cells. Shan GZ, Peng ZG, Li YH, Li D, Li YP, Meng S, Gao LY, Jiang JD, Li ZR. J Antibiot (Tokyo); 2011 Feb 11; 64(2):177-82. PubMed ID: 21179047 [Abstract] [Full Text] [Related]
4. Potent cytotoxic C-11 modified geldanamycin analogues. Tian ZQ, Wang Z, MacMillan KS, Zhou Y, Carreras CW, Mueller T, Myles DC, Liu Y. J Med Chem; 2009 May 28; 52(10):3265-73. PubMed ID: 19405528 [Abstract] [Full Text] [Related]
5. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives. Cheng J, Xie J, Luo X. Bioorg Med Chem Lett; 2005 Jan 17; 15(2):267-9. PubMed ID: 15603937 [Abstract] [Full Text] [Related]
6. Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Mason WS, Cullen J, Saputelli J, Wu TT, Liu C, London WT, Lustbader E, Schaffer P, O'Connell AP, Fourel I. Hepatology; 1994 Feb 17; 19(2):398-411. PubMed ID: 8294097 [Abstract] [Full Text] [Related]
7. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites. Lee K, Ryu JS, Jin Y, Kim W, Kaur N, Chung SJ, Jeon YJ, Park JT, Bang JS, Lee HS, Kim TY, Lee JJ, Hong YS. Org Biomol Chem; 2008 Jan 21; 6(2):340-8. PubMed ID: 18175003 [Abstract] [Full Text] [Related]
9. Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors. Li Z, Jia L, Wang J, Wu X, Hao H, Xu H, Wu Y, Shi G, Lu C, Shen Y. Eur J Med Chem; 2014 Oct 06; 85():359-70. PubMed ID: 25105924 [Abstract] [Full Text] [Related]
16. New non-quinone geldanamycin analogs from genetically engineered Streptomyces hygroscopicus. Wu CZ, Moon AN, Jang JH, Lee D, Kang SY, Park JT, Ahn JS, Hwang BY, Kim YH, Lee HS, Hong YS. J Antibiot (Tokyo); 2011 Jun 06; 64(6):461-3. PubMed ID: 21448187 [No Abstract] [Full Text] [Related]
17. Helioxanthin analogue 8-1 inhibits duck hepatitis B virus replication in cell culture. Ying C, Tan S, Cheng YC. Antivir Chem Chemother; 2010 Jun 06; 21(2):97-103. PubMed ID: 21107018 [Abstract] [Full Text] [Related]
18. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo. Schwock J, Pham NA, Cao MP, Hedley DW. Cancer Chemother Pharmacol; 2008 Apr 06; 61(4):669-81. PubMed ID: 17579866 [Abstract] [Full Text] [Related]
19. Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity. Onodera H, Kaneko M, Takahashi Y, Uochi Y, Funahashi J, Nakashima T, Soga S, Suzuki M, Ikeda S, Yamashita Y, Rahayu ES, Kanda Y, Ichimura M. Bioorg Med Chem Lett; 2008 Mar 01; 18(5):1588-91. PubMed ID: 18243703 [Abstract] [Full Text] [Related]
20. Synthesis and biological evaluation of geldanamycin analogs against human cancer cells. Li YP, Chen JJ, Shen JJ, Cui J, Wu LZ, Wang Z, Li ZR. Cancer Chemother Pharmacol; 2015 Apr 01; 75(4):773-82. PubMed ID: 25681003 [Abstract] [Full Text] [Related] Page: [Next] [New Search]